title: A report from the endocrine society's 94th annual meeting & expo (June 23-26 - Houston, Texas, USA).
abstract: At temperatures above 100 degrees Fahrenheit, but chilly air conditioning inside the George R. Brown convention center, Houston was the endocrine capital of America during June 2012, with the ENDO EXPO 2012 meeting calling attendees from all the states and abroad. Endocrinology is a highly varied specialty, ranging from hormonal disturbances of the pituitary (and in fact acromegaly and Cushing's syndrome were among the stars of this year's meeting therapy-wise) to diabetes, female hormonal disorders and endocrine-mediated malignancies, to mention only a few. New and investigational treatments for these conditions are summarized in the following report, based on the oral and poster presentations during the meeting.
authors.affiliation: Thomson Reuters, Barcelona, Spain. xavier.rabasseda@thomsonreuters.com
authors.forename: X
authors.initials: X
authors.lastname: Rabasseda
mesh_terms: D000307:Adrenal Gland Diseases / Q000188:drug therapy; D003920:Diabetes Mellitus / Q000188:drug therapy; D004700:Endocrine System Diseases / Q000188:drug therapy*; D006801:Humans; D010279:Parathyroid Diseases / Q000188:drug therapy; D010900:Pituitary Diseases / Q000188:drug therapy; D013781:Texas; D013959:Thyroid Diseases / Q000188:drug therapy